Risk Stratification in Acute Coronary Syndrome by Comprehensive Morphofunctional Assessment With Optical Coherence Tomography. 2022

Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

Artificial intelligence enables simultaneous evaluation of plaque morphology and computational physiology from optical coherence tomography (OCT). This study sought to appraise the predictive value of major adverse cardiovascular events (MACE) by combined plaque morphology and computational physiology. A total of 604 patients with acute coronary syndrome who underwent OCT imaging in ≥1 nonculprit vessel during index coronary angiography were retrospectively enrolled. A novel morphologic index, named the lipid-to-cap ratio (LCR), and a functional parameter to evaluate the physiologic significance of coronary stenosis from OCT, namely, the optical flow ratio (OFR), were calculated from OCT, together with classical morphologic parameters, like thin-cap fibroatheroma (TCFA) and minimal lumen area. The 2-year cumulative incidence of a composite of nonculprit vessel-related cardiac death, cardiac arrest, acute myocardial infarction, and ischemia-driven revascularization (NCV-MACE) at 2 years was 4.3%. Both LCR (area under the curve [AUC]: 0.826; 95% CI: 0.793-0.855) and OFR (AUC: 0.838; 95% CI: 0.806-0.866) were superior to minimal lumen area (AUC: 0.618; 95% CI: 0.578-0.657) in predicting NCV-MACE at 2 years. Patients with both an LCR of >0.33 and an OFR of ≤0.84 had significantly higher risk of NCV-MACE at 2 years than patients in whom at least 1 of these 2 parameters was normal (HR: 42.73; 95% CI: 12.80-142.60; P < 0.001). The combination of thin-cap fibroatheroma and OFR also identified patients at higher risk of future events (HR: 6.58; 95% CI: 2.83-15.33; P < 0.001). The combination of LCR with OFR permits the identification of a subgroup of patients with 43-fold higher risk of recurrent cardiovascular events in the nonculprit vessels after acute coronary syndrome.

UI MeSH Term Description Entries

Related Publications

Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
May 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
July 2019, International journal of cardiology,
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
July 2010, Journal of cardiology,
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
April 2015, European heart journal. Cardiovascular Imaging,
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
August 2015, Coronary artery disease,
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
April 2023, Interventional cardiology clinics,
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
January 2016, Expert review of cardiovascular therapy,
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
June 2015, Revista espanola de cardiologia (English ed.),
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
January 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology,
Huihong Hong, and Haibo Jia, and Ming Zeng, and Juan Luis Gutiérrez-Chico, and Yini Wang, and Xiaoling Zeng, and Yuhan Qin, and Chen Zhao, and Miao Chu, and Jiayue Huang, and Lili Liu, and Sining Hu, and Luping He, and Lianglong Chen, and William Wijns, and Bo Yu, and Shengxian Tu
June 2006, The American journal of cardiology,
Copied contents to your clipboard!